Korean J Biol Psychiatry.  2023 Apr;30(1):24-30. 10.22857/kjbp.2023.30.1.004.

Identification of Combined Biomarker for Predicting Alzheimer’s Disease Using Machine Learning

• Kim KY

• KMID: 2541993
• DOI: http://doi.org/10.22857/kjbp.2023.30.1.004

Abstract

Objectives
Alzheimer’s disease (AD) is the most common form of dementia in older adults, damaging the brain and resulting in impaired memory, thinking, and behavior. The identification of differentially expressed genes and related pathways among affected brain regions can provide more information on the mechanisms of AD. The aim of our study was to identify differentially expressed genes associated with AD and combined biomarkers among them to improve AD risk prediction accuracy.
Methods
Machine learning methods were used to compare the performance of the identified combined biomarkers. In this study, three publicly available gene expression datasets from the hippocampal brain region were used.
Results
We detected 31 significant common genes from two different microarray datasets using the limma package. Some of them belonged to 11 biological pathways. Combined biomarkers were identified in two microarray datasets and were evaluated in a different dataset. The performance of the predictive models using the combined biomarkers was superior to those of models using a single gene. When two genes were combined, the most predictive gene set in the evaluation dataset was ATR and PRKCB when linear discriminant analysis was applied.
Conclusions
Combined biomarkers showed good performance in predicting the risk of AD. The constructed predictive nomogram using combined biomarkers could easily be used by clinicians to identify high-risk individuals so that more efficient trials could be designed to reduce the incidence of AD.

Keyword

ZAlzheimer’s disease; Risk prediction; Gene expression; Combined biomarker; Machine learning